GlassScriptPhysician profile
Linda C Selsor
NPI 1588751275
$2,591.90
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $538 · 2020: $389 · 2021: $775 · 2022: $890.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,320.77 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $222.58 | 2019-2022 | |
| Pfizer INC. | $189.22 | 2021-2022 | |
| Janssen Biotech, INC. | $175.99 | 2021-2022 | |
| Amgen INC. | $167.78 | 2022 | |
| Ucb, INC. | $154.64 | 2019-2022 | |
| Lilly USA, LLC | $113.30 | 2021-2022 | |
| Sun Pharmaceutical Industries INC. | $112.42 | 2020-2022 | |
| E.R. Squibb & Sons, L.L.C. | $33.17 | 2022 | |
| Leo Pharma INC. | $29.97 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $26.27 | 2022 | |
| Biofrontera INC. | $16.98 | 2022 | |
| Epi Health, LLC | $15.30 | 2022 | |
| Almirall LLC | $13.51 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Linda Selsor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.